Two groundbreaking diabetes drugs endorsed by EU regulators
By
Alicia Lasek
Feb 02, 2020
A fast-acting version of Liumjev (insulin lispro), and an oral (non-injectable) version of semaglutide have been recommended for approval.
Novo Nordisk announces approval of prefilled insulin pens
Nov 05, 2013
The U.S. Food and Drug Administration has approved Novo Nordisk’s prefilled insulin pens called the NovoLog® FlexTouch® and Levemir® FlexTouch®. FlexTouch® pens’ dosing mechanism ensures...